Surgery Partners reaffirms 2026 revenue outlook of $3.35 billion-$3.45 billion, adjusted EBITDA at least $530 million
SGRY•2026 guidance reaffirmed
Surgery Partners reaffirmed 2026 guidance, excluding the impact of a planned sale of its Idaho Falls facility stakes to Intermountain Health.
- Forecast calls for revenue of $3.35 billion-$3.45 billion.
- Adjusted EBITDA is expected to be at least $530 million.
- The Idaho Falls transaction values the two facilities at about $1.15 billion; consideration to Surgery Partners is about $795 million, subject to adjustments.
